Document is current

Any future updates will be listed below

A phase I study to investigate the metabolism, excretion, and pharmacokinetics of [14C]fruquintinib, a novel oral selective VEGFR inhibitor, in healthy Chinese male volunteers

Crossref DOI link: https://doi.org/10.1007/s00280-017-3394-6

Published Online: 2017-07-20

Published Print: 2017-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark